(Q71868243)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7607932%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Administration of nicotinamide during chart: pharmacokinetics, dose escalation, and clinical toxicity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7607932%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Administration of nicotinamide during chart: Pharmacokinetics, dose escalation, and clinical toxicity (English)

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00022-Q

13 June 2024

1 reference

1 reference

P. J. Hoskin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607932

13 June 2024

M. R. Stratford

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607932

13 June 2024

M. I. Saunders

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607932

13 June 2024

D. W. Hall

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607932

13 June 2024

M. F. Dennis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607932

13 June 2024

A. Rojas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607932

13 June 2024

language of work or name

English

0 references

publication date

1 July 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7607932%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

15 July 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7607932

full work available at URL

13 June 2024

https://api.elsevier.com/content/article/PII:036030169500022Q?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00022-Q

https://api.elsevier.com/content/article/PII:036030169500022Q?httpAccept=text/plain

13 June 2024

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00022-Q

International Journal of Radiation Oncology Biology Physics

13 June 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7607932%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7607932%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7607932%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

1111-1119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7607932%20AND%20SRC:MED&resulttype=core&format=json

Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo

21 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00022-Q

Radiosensitization by nicotinamide in vivo: a greater enhancement of tumor damage compared to that of normal tissues.

13 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00022-Q

Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy

13 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00022-Q

A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments

13 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00022-Q

ARCON: accelerated radiotherapy with carbogen and nicotinamide

13 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00022-Q

Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations

13 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00022-Q

Should carbogen and nicotinamide be given throughout the full course of fractionated radiotherapy regimens?

13 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00022-Q

Extrapolations from laboratory and preclinical studies for the use of carbogen and nicotinamide in radiotherapy

13 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00022-Q

High-performance liquid chromatographic determination of nicotinamide and its metabolites in human and murine plasma and urine

13 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00022-Q

Pharmacokinetics of nicotinamide and its effect on blood pressure, pulse and body temperature in normal human volunteers

13 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00022-Q

Acute effects of accelerated radiotherapy in combination with carbogen breathing and nicotinamide (ARCON)

13 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00022-Q

13 June 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7607932%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference